Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Vekic, D. Radovanovic, J. Živanović (2003)[Primary lymphoma of the small intestine].
Medicinski pregled, 56 1-2
R. Piekarz, J. Wright, R. Frye, S. Allen, D. Joske, M. Kirschbaum, I. Lewis, M. Prince, Sonali Smith, E. Jaffe, S. Bates (2008)Final Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL).
M. Okuda, J. Nomura, H. Tateno, J. Kameoka, Takeshi Sasaki (2002)CD56 positive intestinal T-cell lymphoma: treatment with high dose chemotherapy and autologous peripheral blood stem cell transplantation.
Internal medicine, 41 9
A. Al-Toma, W. Verbeek, M. Hadithi, B. Blomberg, C. Mulder (2007)Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience
C. Dubé, A. Rostom, R. Sy, A. Cranney, N. Saloojee, C. Garritty, M. Sampson, Li Zhang, F. Yazdi, V. Mamaladze, I. Pan, Joanne Macneil, D. Mack, D. Patel, D. Moher (2005)The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review.
Gastroenterology, 128 4 Suppl 1
R. deLeeuw, A. Zettl, Erdwine Klinker, E. Haralambieva, Magan Trottier, R. Chari, Yong-sheng Ge, R. Gascoyne, A. Chott, H. Müller-hermelink, W. Lam (2007)Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes.
Gastroenterology, 132 5
G. Dueck, N. Chua, A. Prasad, D. Stewart, D. White, R. vanderJagt, J. Johnston, A. Belch, T. Reiman (2009)Activity of lenalidomide in a phase II trial for T-cell lymphoma: Report on the first 24 cases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 15_suppl
M. Goerres, J. Meijer, P. Wahab, J. Kerckhaert, P. Groenen, J. Krieken, Cjj Mulder (2003)Azathioprine and prednisone combination therapy in refractory coeliac disease
Alimentary Pharmacology & Therapeutics, 18
W.Martin Howell, S. Leung, David Jones, Imad Nakshabendi, Margaret Hall, Jerry Lanchbury, P. Ciclitira, Dennis Wrigh (1995)HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy.
Human immunology, 43 1
M. Hadithi, M. Mallant, J. Oudejans, J. Waesberghe, C. Mulder, E. Comans (2006)18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 47 10
W. Holtmeier, W. Caspary (2006)Celiac disease
Orphanet Journal of Rare Diseases, 1
R. Furman, L. Gore, F. Ravandi, D. Hoelzer (2006)Forodesine IV (Bcx-1777) Is Clinically Active in Relapsed/Refractory T-Cell Leukemia: Results of a Phase II Study (Interim Report).
Mrcp MB, Dr. MRCPath, Mrcp BSc, M. MRCPath (2005)Malignant histiocytosis of the intestine
Digestive Diseases and Sciences, 24
A. Diamanti, F. Colistro, A. Calce, R. Devito, F. Ferretti, A. Minozzi, A. Santoni, M. Castro (2006)Clinical Value of Immunoglobulin A Antitransglutaminase Assay in the Diagnosis of Celiac Disease
E. Glatstein (2008)18F-FDG PET Versus CT for the Detection of Enteropathy-Associated T-Cell Lymphoma in Refractory Celiac Disease
Yearbook of Oncology, 2008
A. Fasano, I. Berti, T. Gerarduzzi, T. Not, R. Colletti, S. Drago, Y. Elitsur, P. Green, S. Guandalini, I. Hill, M. Pietzak, A. Ventura, M. Thorpe, Deborah Kryszak, F. Fornaroli, S. Wasserman, J. Murray, K. Horváth (2003)Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study.
Archives of internal medicine, 163 3
A. Al-Toma, Otto Visser, Hyacintha Roessel, B. Blomberg, W. Verbeek, P. Scholten, Gert Ossenkoppele, P. Huijgens, C.J.J. Mulder (2007)Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells.
Blood, 109 5
M. Nickelsen, M. Ziepert, S. Zeynalova, B. Glass, B. Metzner, M. Leithaeuser, H. Mueller-Hermelink, M. Pfreundschuh, N. Schmitz (2009)High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
Annals of oncology : official journal of the European Society for Medical Oncology, 20 12
C. Rongey, Ivana Micallef, T. Smyrk, J. Murray (2006)Successful Treatment of Enteropathy-Associated T Cell Lymphoma with Autologous Stem Cell Transplant
Digestive Diseases and Sciences, 51
O. O’Connor, S. Horwitz, P. Hamlin, C. Portlock, C. Moskowitz, D. Sarasohn, E. Neylon, Jill Mastrella, Rachel Hamelers, Barbara Macgregor-Cortelli, Molly Patterson, V. Seshan, F. Sirotnak, M. Fleisher, D. Mould, M. Saunders, A. Zelenetz (2009)Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 26
S. Sallah, J. Wan, N. Nguyen (2001)Treatment of refractory T‐cell malignancies using gemcitabine
British Journal of Haematology, 113
P. Zinzani, M. Magagnoli, M. Bendandi, G. Orcioni, F. Gherlinzoni, P. Albertini, S. Pileri, S. Tura (1998)Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients.
Annals of oncology : official journal of the European Society for Medical Oncology, 9 12
C. Mulder, P. Wahab, J. Meijer, Els Metselaar (2001)A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease
European Journal of Gastroenterology & Hepatology, 13
A. Chott, M. Vesely, I. Simonitsch, I. Mosberger, H. Hanak (1999)Classification of intestinal T-cell neoplasms and their differential diagnosis.
American journal of clinical pathology, 111 1 Suppl 1
Wahab, Crusius, Meijer, Uil, Mulder (2000)Cyclosporin in the treatment of adults with refractory coeliac disease—an open pilot study
Alimentary Pharmacology & Therapeutics, 14
P. Howdle, P. Jalal, G. Holmes, R. Houlston (2003)Primary small-bowel malignancy in the UK and its association with coeliac disease.
QJM : monthly journal of the Association of Physicians, 96 5
E. Bernstein, P. Whitington (1988)Successful treatment of atypical sprue in an infant with cyclosporine.
Gastroenterology, 95 1
W. Verbeek, J. Water, A. Al-Toma, J. Oudejans, C. Mulder, V. Coupé (2008)Incidence of enteropathy - associated T-cell lymphoma: A nation-wide study of a population-based registry in The Netherlands
Scandinavian Journal of Gastroenterology, 43
C. Cellier, E. Delabesse, C. Helmer, N. Patey, C. Matuchansky, B. Jabri, E. Macintyre, N. Cerf‐Bensussan, N. Brousse (2000)Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma
The Lancet, 356
Wright Dh (1997)Enteropathy associated T cell lymphoma.
Cancer surveys, 30
A. Al-Toma, W. Verbeek, O. Visser, K. Kuijpers, J. Oudejans, H. Kluin-Nelemans, C. Mulder, P. Huijgens (2007)Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 39 7
Sarah Ondrejka, D. Jagadeesh (2016)Enteropathy-Associated T-Cell Lymphoma
Current Hematologic Malignancy Reports, 11
P. Reimer, T. Rüdiger, E. Geissinger, F. Weissinger, C. Nerl, N. Schmitz, A. Engert, H. Einsele, H. Müller-hermelink, M. Wilhelm (2009)Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 1
A. Al-Toma, M. Goerres, J. Meijer, B. Blomberg, P. Wahab, J. Kerckhaert, C. Mulder (2006)Cladribine therapy in refractory celiac disease with aberrant T cells.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 4 11
J. Spencer, P. Isaacson (1988)Do vascular addressins mediate tissue specific lymphocyte extravasation?
The Journal of Pathology, 156
P. Isaacson, M. Du (2005)Gastrointestinal lymphoma: where morphology meets molecular biology
The Journal of Pathology, 205
P. Domizio, Owen Ra, Shepherd Na, T. Ic, Norton Aj (1993)Primary Lymphoma of the Small Intestine A. Clinicopathological Study of 119 Cases
The American Journal of Surgical Pathology, 17
J. Gale, P. Simmonds, G. Mead, J. Sweetenham, D. Wright (2000)Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 4
M. Mallant, M. Hadithi, A. Al-Toma, M. Kater, M. Jacobs, R. Manoliu, C. Mulder, J. Waesberghe (2007)Abdominal computed tomography in refractory coeliac disease and enteropathy associated T-cell lymphoma.
World journal of gastroenterology, 13 11
T. Salmi, P. Collin, I. Korponay-Szabó, K. Laurila, Jukka Partanen, H. Huhtala, R. Király, L. Lorand, T. Reunala, M. Mäki, K. Kaukinen (2006)Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits
A. Chott, W. Haedicke, I. Mosberger, M. Födinger, M. Födinger, K. Winkler, C. Mannhalter, H. Müller-hermelink (1998)Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology.
The American journal of pathology, 153 5
A. Zettl, G. Ott, Angela Makulik, T. Katzenberger, P. Starostik, T. Eichler, B. Puppe, M. Bentz, H. Müller-hermelink, A. Chott (2002)Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma.
The American journal of pathology, 161 5
Errol Berman, NP Zauber, RR Rickert, T. Diss, P. Isaacson (1998)Enteropathy-associated T cell lymphoma with brain involvement.
Journal of clinical gastroenterology, 26 4
N. Mounier, C. Gisselbrecht, J. Brière, C. Haioun, P. Feugier, F. Offner, C. Récher, A. Stamatoullas, F. Morschhauser, M. Macro, C. Thieblemont, A. Sonet, B. Fabiani, F. Reyes (2004)All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Annals of oncology : official journal of the European Society for Medical Oncology, 15 12
S. Daum, R. Ullrich, W. Heise, B. Dederke, H. Foss, H. Stein, E. Thiel, M. Zeitz, E. Riecken (2003)Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 14
J. Delabie, H. Holte, J. Vose, F. Ullrich, E. Jaffe, K. Savage, J. Connors, L. Rimsza, N. Harris, K. Müller-Hermelink, T. Rüdiger, B. Coiffier, R. Gascoyne, F. Berger, K. Tobinai, W. Au, R. Liang, E. Montserrat, E. Hochberg, S. Pileri, M. Federico, B. Nathwani, J. Armitage, D. Weisenburger (2011)Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.
Blood, 118 1
J. Spencer, N. Cerf‐Bensussan, A. Jarry, N. Brousse, D. Guy-Grand, Krajewski As, P. Isaacson (1988)Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes.
The American journal of pathology, 132 1
A. Tutt, M. Brada, S. Sampson (1997)Enteropathy associated T cell lymphoma presenting as an isolated CNS lymphoma three years after diagnosis of coeliac disease: T cell receptor polymerase chain reaction studies failed to show the original enteropathy to be a clonal disorder.
M. Sieniawski, N. Angamuthu, K. Boyd, R. Chasty, J. Davies, P. Forsyth, F. Jack, S. Lyons, P. Mounter, P. Revell, S. Proctor, A. Lennard (2010)Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.
Blood, 115 18
A. Murray, E. Cuevas, D. Jones, D. Wright (1995)Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma.
The American journal of pathology, 146 2
C. Catassi, E. Fabiani, G. Corrao, M. Barbato, A. Renzo, A. Carella, A. Gabrielli, P. Leoni, A. Carroccio, M. Baldassarre, P. Bertolani, P. Caramaschi, M. Sozzi, G. Guariso, U. Volta, G. Corazza (2002)Risk of non-Hodgkin lymphoma in celiac disease.
JAMA, 287 11
Enteropathy-associated T-cell lymphoma (EATL) is a rare non-Hodgkin lymphoma of T-cell origin. The recent 2008 World Health Organization classification of hematologic malignancies distinguishes between two types of EATL. The disease is associated with celiac disease, particularly with its late, adult onset. Currently, there are no standardized diagnostic or treatment protocols for EATL, mostly because of its rarity. Historically, the patients have been treated with anthracycline-based chemotherapy with or without surgery. The outcome of patients with EATL treated with these approaches is poor. The reported death rates in the biggest studies are approximately 80–84%, with median progression-free survival (PFS) of 3.4–6.0 months and overall survival of 7.1–10.0 months. The 5-year PFS ranged from 3.2% to 18% and OS from 19.7% to 20%. The results of a novel induction regimen with ifosfamide, etoposide, and epirubicin alternating with intermediate-dose methotrexate followed by autologous stem cell transplantation (ASCT) are more promising, with a 5-year PFS of 52% and OS of 60%. The alternative approach, with a more common induction with cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone followed by ASCT has also delivered promising results, with a 3-year PFS of 52% and OS of 47%. This review summarizes recently published data on epidemiology and clinical features, as well as standard and novel treatments including high-dose chemotherapy with ASCT and their outcome in EATL.
Current Hematologic Malignancy Reports – Springer Journals
Published: Sep 13, 2011
Access the full text.
Sign up today, get DeepDyve free for 14 days.